Search Results - "Lang, Noemie"
-
1
PET-adapted approaches to primary therapy for advanced Hodgkin lymphoma
Published in Therapeutic Advances in Hematology (01-06-2020)“…Recent results of randomized phase III studies of FDG-PET-adapted therapy for advanced Hodgkin lymphoma (HL) have clearly demonstrated benefit to alteration of…”
Get full text
Book Review Journal Article -
2
Nab-PIPAC: a phase IB study protocol of intraperitoneal cisplatin and nab-paclitaxel administered by pressurised intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of advanced malignancies confined to the peritoneal cavity
Published in BMJ open (05-01-2023)“…Intraperitoneal dissemination is a major problem resulting in very poor prognosis and a rapid marked deterioration in the quality of life of patients…”
Get full text
Journal Article -
3
-
4
Case report: From sequence to solution: tailoring treatment for transformed follicular lymphoma (DLBCL) through next generation sequencing study
Published in Frontiers in oncology (29-02-2024)“…Immune checkpoint blockade (ICB) has indeed transformed the outlook for many advanced-stage solid tumors, yet its effectiveness in hematological malignancies…”
Get full text
Journal Article -
5
CAR T-Based Therapies in Lymphoma: A Review of Current Practice and Perspectives
Published in Biomedicines (01-08-2022)“…While more than half of non-Hodgkin lymphomas (NHL) can be cured with modern frontline chemoimmunotherapy regimens, outcomes of relapsed and/or refractory…”
Get full text
Journal Article -
6
Evolving management strategies for lymphomas during the COVID-19 pandemic
Published in Leukemia & lymphoma (16-04-2021)“…The evolving CoViD-19 pandemic has raised unprecedented challenges for physicians who face significant constraints in medical resources and cancer therapies…”
Get full text
Journal Article -
7
Efficacy of Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Narrative Review
Published in Biomedicines (01-06-2023)“…Immune checkpoint blockade (ICB) has revolutionized the prognosis of several advanced-stage solid tumors. However, its success has been far more limited in…”
Get full text
Journal Article -
8
Decision-Making among Experts in Advanced Hodgkin Lymphoma
Published in Oncology (01-03-2023)“…In the treatment of advanced Hodgkin lymphoma (aHL), based on guidelines a multitude of treatment options are available. The availability of PET-guided…”
Get more information
Journal Article -
9
Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study
Published in Swiss medical weekly (30-03-2023)“…Carriers of germline pathogenic variants of the BRCA1 gene (gBRCA1) tend to have a higher incidence of haematological toxicity upon exposure to chemotherapy…”
Get full text
Journal Article -
10
Risk stratification for relapsed/refractory classical Hodgkin lymphoma integrating pretransplant Deauville score and residual metabolic tumor volume
Published in American journal of hematology (01-05-2022)“…Pretransplant Deauville score (DS) is an imaging biomarker used for risk stratification in relapsed/refractory classical Hodgkin lymphoma (cHL). However, the…”
Get full text
Journal Article -
11
Effectiveness of fractionated rituximab in preventing tumor lysis syndrome in aggressive B‐cell lymphoma: Insights from real‐life clinical practice
Published in Cancer reports (01-10-2024)“…Background Tumor lysis syndrome (TLS) is a potentially life‐threatening condition resulting from the rapid destruction of malignant cells, leading to…”
Get full text
Journal Article -
12
Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literature
Published in Familial cancer (01-07-2023)“…BRCA1 and BRCA2 play a central role in DNA repair and their germline pathogenic variants (g BRCA ) confer a high risk for developing breast and ovarian cancer…”
Get full text
Journal Article -
13
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences
Published in Exploration of targeted anti-tumor therapy (2022)“…Antibody-drug conjugates (ADCs) are a recent, revolutionary approach for malignancies treatment, designed to provide superior efficacy and specific targeting…”
Get full text
Journal Article -
14
Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
Published in Scientific reports (27-04-2020)“…BRCA1/BRCA2 genes play a central role in DNA repair and their mutations increase sensitivity to DNA-damaging agents. There are conflicting data regarding the…”
Get full text
Journal Article -
15
A risk model for relapsed/refractory aggressive NHL integrating clinical risk factors and pretransplant Deauville score
Published in Blood advances (24-11-2020)“…There are limited data regarding the combined value of the pretransplant Deauville score (DS) from a positron emission tomography scan and clinical risk…”
Get full text
Journal Article -
16
Risk Stratification for Relapsed/Refractory Classical Hodgkin Lymphoma Integrating Pretransplant Deauville Score and Residual Metabolic Tumor Volume
Published in Blood (23-11-2021)“…Introduction Positron emission tomography (PET) positivity before autologous stem cell transplantation (ASCT) predicts poor prognosis in relapsed/refractory…”
Get full text
Journal Article -
17
Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
Published in Scientific reports (02-11-2020)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
18
Post-transplant lymphoproliferative disorders
Published in Revue médicale suisse (17-05-2023)“…Post-transplant lymphoproliferative disorders (PTLD) represent a typical complication of transplant recipients. Their incidence varies according to the…”
Get more information
Journal Article -
19
Monoclonal gammopathies: from MGUS to multiple myeloma
Published in Revue médicale suisse (15-05-2019)“…Monoclonal plasma cell gammopathies (MPCG) describe several forms of abnormal plasma cell proliferation. Their prevalence increases with age. Initially…”
Get more information
Journal Article -
20
Progressive cutaneous and pulmonary lesions without infectious etiology: two cases reports of sweet syndrome with pulmonary involvement
Published in Praxis (Bern. 1994) (17-09-2014)“…Sweet syndrome is a non infectious febrile disease with a neutrophilic infiltrate of dermis. Extracutaneous involvement can occur. We report two cases of Sweet…”
Get more information
Journal Article